Abstract
Long-acting injectable antiretroviral therapy (LA-ART) is a powerful new addition to the treatments available for patients living with HIV, but broad acceptance and uptake could be compromised by what we know about patients' and clinicians' experiences with long-acting injectable antipsychotics (LAI-APs). Treatment of stigmatized conditions, such as psychiatric illness or HIV, using long-acting injection is ethically fraught with patients' fear of coercion and forced administration. Strategies that emphasize patient-centered, patient-directed care and that place limits on when LAI can be administered forcibly can help promote LA-ART's acceptance and use.
Original language | English (US) |
---|---|
Pages (from-to) | 405-409 |
Number of pages | 5 |
Journal | AMA Journal of Ethics |
Volume | 23 |
Issue number | 5 |
DOIs | |
State | Published - May 2021 |
Externally published | Yes |
ASJC Scopus subject areas
- Issues, ethics and legal aspects
- Health(social science)
- Health Policy